189
Participants
Start Date
September 28, 2020
Primary Completion Date
January 31, 2024
Study Completion Date
June 30, 2026
Morphine
The dose interval for morphine will be either every 3 or 4 hours, per hospital practice. Clinical teams are asked to wean study drug at least every 24 hours.
Methadone
The dose interval for methadone will be every 8 or 12 hours, per hospital practice. Clinical teams are asked to wean study drug at least every 24 hours.
MedStar Franklin Square, Hyattsville
West Virginia University Hospital, Morgantown
RTI International, Durham
University of Alabama at Birmingham, Birmingham
University of Tennessee Health Science Center, Memphis
The University of Tennessee Health Science Center, Memphis
Nationwide Childeren's Hospital, Columbus
Ohio State University Hospital, Columbus
Metrohealth, Cleveland
Central Michigan University, Detroit
University of Iowa, Iowa City
Sanford Health, Sioux Falls
Washington University School of Medicine, St Louis
Children's Mercy Hospital, Kansas City
Tulane University Health Science Center, New Orleans
Ochsner Medical Regional Hospital, Kenner
Ochsner Baptist Clinical Trials Unit, New Orleans
University of Arkansas Medical Sciences, Little Rock
University of Arizona, Tucson
University of New Mexico, Albuquerque
Sharp Mary Birch Hospital for Women and Newborns, San Diego
Loma Linda University Medical Center, Loma Linda
University of Massachusetts Memorial Medical Center-West Campus, Worcester
Women & Infants Hospital of Rhode Island, Providence
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program
NETWORK